Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TVTX | GPCR | LQDA | ||
| Company | Travere Therapeutics Inc | Structure Therapeutics Inc | Liquidia Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 39.83 | 54.63 | 40.00 | ||
| High | 40.00 | 55.54 | 41.98 | ||
| Low | 38.12 | 53.08 | 39.52 | ||
| Latest | 39.54 | 53.50 | 41.40 | ||
| Change | -1.41 | -0.75 | +1.28 | ||
| % Change | -3.44% | -1.38% | +3.19% | ||
| Volume | 4,562,000 | 548,100 | 1,184,400 | ||
| 20-Day Average Volume | 2,602,615 | 1,007,540 | 1,043,140 | ||
| Previous Close | 40.95 | 54.25 | 40.12 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 31.00 | 50.78 | 37.60 | ||
| 20-Day Raw Stochastic | 78.03% | 74.32% | 92.54% | ||
| 20-Day Relative Strength | 65.73 | 45.85 | 60.80 | ||
| Weighted Alpha | +104.34 | +19.85 | +152.97 | ||
| Today's Opinion | 56% Buy | 8% Buy | 100% Buy | ||
| Previous Opinion | 56% Buy | 8% Buy | 100% Buy | ||
| Last Month's Opinion | 24% Sell | 24% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +25.76% since 04/09/26 | -2.97% since 04/09/26 | +2.68% since 04/09/26 | ||
| Low | 28.29 on 04/10/26 | 51.21 on 04/15/26 | 37.55 on 04/13/26 | ||
| High | 43.31 on 04/14/26 | 56.40 on 04/13/26 | 41.98 on 04/16/26 | ||
| 1-Month | |||||
| %Chg | +41.06% since 03/16/26 | -5.56% since 03/16/26 | +15.97% since 03/16/26 | ||
| Low | 26.15 on 03/20/26 | 42.72 on 03/30/26 | 34.21 on 03/24/26 | ||
| High | 43.31 on 04/14/26 | 57.47 on 03/17/26 | 41.98 on 04/16/26 | ||
| 3-Month | |||||
| %Chg | +41.87% since 01/16/26 | -39.64% since 01/16/26 | +9.15% since 01/16/26 | ||
| Low | 26.15 on 03/20/26 | 42.72 on 03/30/26 | 29.12 on 02/26/26 | ||
| High | 43.31 on 04/14/26 | 94.77 on 01/20/26 | 46.67 on 02/03/26 | ||
| 6-Month | |||||
| %Chg | +43.73% since 10/16/25 | +94.12% since 10/16/25 | +78.60% since 10/16/25 | ||
| Low | 22.59 on 01/13/26 | 25.59 on 10/22/25 | 21.94 on 10/23/25 | ||
| High | 43.31 on 04/14/26 | 94.90 on 12/08/25 | 46.67 on 02/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,652,310 | 3,790,047 | 3,647,920 | ||
| Shares Outstanding, K | 92,370 | 70,842 | 88,114 | ||
| Annual Sales | 490,730,000 | 0 | 158,320,000 | ||
| Annual Net Income | -25,550,000 | -141,200,000 | -68,920,000 | ||
| Last Quarter Sales | 129,690,000 | 0 | 92,020,000 | ||
| Last Quarter Net Income | 2,730,000 | 33,000,000 | 14,550,000 | ||
| 60-Month Beta | 0.86 | -1.17 | 0.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.03 on 02/19/26 | -0.49 on 02/26/26 | 0.15 on 03/05/26 | ||
| Latest Earnings Date | 05/07/26 | 05/14/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||